Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: FLARE

Cryopyrin-Associated Periodic Syndromes: Difficult to Recognize, Diagnose, Treat

Philip J. Hashkes, MD, MSc, & Ronald M. Laxer, MDCM, FRCPC  |  October 1, 2014

Two case studies demonstrate the difficulty, delay in recognizing this rare autoinflammatory disease

Filed under:Career DevelopmentConditionsEducation & TrainingOther Rheumatic ConditionsProfessional TopicsResearch Rheum Tagged with:autoinflammatoryCAPSClinicalDiagnosispatient careResearchrheumatologistSteroidsTreatment

Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  September 1, 2014

Plus, rheumatology drug news, safety updates

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ataciceptBiologicsdrugKaufmanmavrilimumabResearchRheumatoid arthritisrheumatologistrheumatologyrituximabSafetySystemic lupus erythematosus

Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians

Kathy Holliman  |  September 1, 2014

Infectious Diseases Society of America recommends both physician groups educate patients, household members on importance of vaccines

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug Updates Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugGuidelinesHollimanimmunocompromisedMethotrexatepatient carerheumatologistSafetyvaccination

EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis

Thomas R. Collins  |  August 1, 2014

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryBiologicsCollinsdrugEULARGlucocorticoidsinfliximabInternationalMethotrexateResearchRheumatoid arthritisrheumatologySafety

Coding Corner Question: August

From the College  |  August 1, 2014

Level 4 coding for a follow-up visit by a patient with gout

Filed under:Billing/CodingConditionsFrom the CollegeGout and Crystalline ArthritisPractice Support Tagged with:BillingCodingcrystal arthritisGoutPractice Managementrheumatologistrheumatology

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ActemrabaricitinibbelimumabBiologicsdrugLupusResearchRheumatoid arthritisSafetySystemic lupus erythematosustocilizumabzoledronic acid

Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support

Gretchen Henkel  |  July 1, 2014

Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugEULARGlucocorticoidsLupusprednisoneRheumatoid arthritisrheumatologistrituximabSLESystemic lupus erythematosus

Hospitalists Gain Insight on Signs, Symptoms of Infection Among Inpatients on Biologic Drugs

Richard Quinn  |  June 6, 2014

Rheumatologist at Society of Hospital Medicine conference provides treatment recommendations for hospital patients with rheumatic disease

Filed under:Practice Support Tagged with:biologic drugsInfectioninpatientrheumatology

Clinical Applications of Dual-Energy Computed Tomography for Rheumatology

Nicola Dalbeth, MBChB, MD, FRACP  |  June 1, 2014

Advanced imaging technique allows physicians to detect deposition of monosodium urate crystals not apparent in physical exams and better diagnose gout

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:crystal arthritisDECTGoutimagingrheumatologistTechnologyUltrasound

Synthetic Hydrogel (aka Squishy Gel) Could Revolutionize Arthritis Treatment

Richard Quinn  |  April 8, 2014

Squishy gel could include a chemical compound capable of helping repair, restore or regenerate cartilage in a joint.

Filed under:Research Rheum Tagged with:JIA

  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 68
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences